Aprea Therapeutics Inc (APRE) USD0.001

Sell:$0.67Buy:$0.70Price increased$0.01 (1.65%)

Prices delayed by at least 15 minutes
Sell:$0.67
Buy:$0.70
Change:Price increased$0.01 (1.65%)
Prices delayed by at least 15 minutes
Sell:$0.67
Buy:$0.70
Change:Price increased$0.01 (1.65%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 March 2026
Richard PetersDirector
Buy
Regular purchase transaction
123,915$0.81$99,999.41123,915
31 March 2026
John P HamillCFO
Buy
Regular purchase transaction
30,978$0.81$24,999.2530,978
30 January 2026
Oren GiladPresident/CEO
Buy
Regular purchase transaction
28,100$0.89$25,009.00373,720
30 January 2026
John P HamillCFO
Buy
Regular purchase transaction
5,700$0.89$5,073.0033,433
10 December 2025
Marc DueyIndependent Director
Buy
Regular purchase transaction
21,459$1.17$24,999.74256,155
10 December 2025
John P HamillCFO
Buy
Regular purchase transaction
5,000$1.17$5,825.0027,733
10 December 2025
Oren GiladPresident/CEO
Buy
Regular purchase transaction
21,459$1.17$24,999.7421,459

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 March 2026
Richard PetersDirector
Buy
Regular purchase transaction
123,915$0.81$99,999.41123,915
30 January 2026
Oren GiladPresident/CEO
Buy
Regular purchase transaction
28,100$0.89$25,009.00373,720
10 December 2025
Marc DueyIndependent Director
Buy
Regular purchase transaction
21,459$1.17$24,999.74256,155
10 December 2025
Oren GiladPresident/CEO
Buy
Regular purchase transaction
21,459$1.17$24,999.7421,459
31 March 2026
John P HamillCFO
Buy
Regular purchase transaction
30,978$0.81$24,999.2530,978

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.